1 November 2024 false No description of principal activity Taxfiler 2024.6 11074438business:PrivateLimitedCompanyLtd2024-11-012025-10-31 110744382024-10-31 110744382024-11-012025-10-31 11074438business:AuditExemptWithAccountantsReport2024-11-012025-10-31 11074438business:FilletedAccounts2024-11-012025-10-31 110744382025-10-31 11074438business:Director12024-11-012025-10-31 11074438business:RegisteredOffice2024-11-012025-10-31 110744382024-10-31 11074438core:WithinOneYear2025-10-31 11074438core:WithinOneYear2024-10-31 11074438core:ShareCapitalcore:PreviouslyStatedAmount2025-10-31 11074438core:ShareCapitalcore:PreviouslyStatedAmount2024-10-31 11074438core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-10-31 11074438core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-10-31 11074438core:PreviouslyStatedAmount2025-10-31 11074438core:PreviouslyStatedAmount2024-10-31 11074438business:SmallEntities2024-11-012025-10-31 11074438countries:EnglandWales2024-11-012025-10-31 11074438core:FurnitureFittings2024-11-012025-10-31 11074438core:ComputerEquipment2024-11-012025-10-31 11074438core:Goodwill2024-10-31 11074438core:Goodwill2025-10-31 11074438core:Goodwill2024-11-012025-10-31 11074438core:FurnitureFittings2024-10-31 11074438core:ComputerEquipment2024-10-31 11074438core:FurnitureFittings2025-10-31 11074438core:ComputerEquipment2025-10-31 110744382023-05-012024-10-31 iso4217:GBP xbrli:pure
Company Registration No. 11074438 (England and Wales)
Jada Pharm Limited Unaudited accounts for the year ended 31 October 2025
Jada Pharm Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Jada Pharm Limited Company Information for the year ended 31 October 2025
Director
Rahul Patel
Company Number
11074438 (England and Wales)
Registered Office
44 Cannon Hill London N14 6LH England
Accountants
BPACL Accountancy Services Limited 83 Cowley Hill Borehamwood Hertfordshire WD6 5NA
- 3 -
Jada Pharm Limited Statement of financial position as at 31 October 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Intangible assets
4
138,915 
185,220 
Tangible assets
5
2,808 
4,109 
141,723 
189,329 
Current assets
Inventories
51,240 
44,268 
Debtors
6
82,500 
50,740 
Cash at bank and in hand
86,294 
1,548 
220,034 
96,556 
Creditors: amounts falling due within one year
7
(423,873)
(346,315)
Net current liabilities
(203,839)
(249,759)
Total assets less current liabilities
(62,116)
(60,430)
Provisions for liabilities
Deferred tax
(702)
(1,004)
Net liabilities
(62,818)
(61,434)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(62,918)
(61,534)
Shareholders' funds
(62,818)
(61,434)
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 October 2026 and were signed on its behalf by
Rahul Patel Director Company Registration No. 11074438
- 4 -
Jada Pharm Limited Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
Jada Pharm Limited is a private company, limited by shares, registered in England and Wales, registration number 11074438. The registered office is 44 Cannon Hill, London, N14 6LH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% Straight line method
Computer equipment
20% Reducing balance method
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 November 2024
463,053 
At 31 October 2025
463,053 
Amortisation
At 1 November 2024
277,833 
Charge for the year
46,305 
At 31 October 2025
324,138 
Net book value
At 31 October 2025
138,915 
At 31 October 2024
185,220 
- 5 -
Jada Pharm Limited Notes to the Accounts for the year ended 31 October 2025
5
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 November 2024
5,408 
8,019 
13,427 
At 31 October 2025
5,408 
8,019 
13,427 
Depreciation
At 1 November 2024
4,809 
4,509 
9,318 
Charge for the year
599 
702 
1,301 
At 31 October 2025
5,408 
5,211 
10,619 
Net book value
At 31 October 2025
- 
2,808 
2,808 
At 31 October 2024
599 
3,510 
4,109 
6
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
6,669 
3,682 
Trade debtors
57,427 
31,172 
Accrued income and prepayments
8,591 
15,886 
Other debtors
9,813 
- 
82,500 
50,740 
7
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Bank loans and overdrafts
- 
222,997 
Trade creditors
95,391 
76,898 
Amounts owed to group undertakings and other participating interests
39,353 
- 
Taxes and social security
14,898 
13,914 
Other creditors
- 
3,879 
Loans from directors
273,851 
28,627 
Accruals
380 
- 
423,873 
346,315 
8
Average number of employees
During the year the average number of employees was 3 (2024: 5).
- 6 -